Jump to navigation
The latest clinical and political news for Australian Neurologists
It took 72 hours for Vanessa Potter to lose her sight.
A drug used for rheumatoid arthritis seems to bring benefits
Almost a third of rural patients at risk of stroke are not getting anticoagulant therapy.
Australian specialist says 2017 was a watershed year
Not surprisingly, several companies have left this territory in recent years.
Launch of Australia's first clinical guidelines on diagnosis and management of paediatric stroke.
Clare Pain catches a glimpse of the raw material of neurological research.
US neurologists say the Brave Dreams trial shows venoplasty is useless.
Sub-groups formerly considered at risk can get standard treatment.
The author requested the retractions.
While survival rates for most cancers continue to improve in Australia, brain cancers aren’t seeing the same success...
The case of a patient who was interested in a quick fix.
Cutting through the hype around Souvenaid
But we do better in other aspects of stroke prevention.
How music hit the right note.
It analyses facial expressions to see whether patients are in pain
A new study shines a light on the issue.
The first RCT to document efficacy of a remyelinating drug in MS
But stroke on the decline, according to the latest figures.
Football associations in the UK move to increase awareness and research efforts.
Australian Doctor Group (ADG) is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.